Tianyu Guo1, Zhe Wang2, Yefu Liu1. 1. Department of Hepatobiliary Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China. 2. Department of Gastrointestinal Oncology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China.
Abstract
BACKGROUND: Gastrointestinal malignant cancers affect many sites in the intestinal tract, including the colon. In this study, we purposed to improve prognostic predictions for colon cancer (CC) patients by establishing a novel biosignature of immune-related genes (IRGs) based on the tumor microenvironment (TME). METHODS: Using the estimation of stromal and immune cells in malignant tumor tissues using expression data (ESTIMATE) algorithm, we calculated the stromal and immune scores of every CC patient extracted from The Cancer Genome Atlas (TCGA). We then identified 4 immune-related messenger RNA (mRNA) biosignatures through a Cox and least absolute shrinkage and selection operator (LASSO) univariate analysis, and a Cox multivariate analysis. Relationships between tumor immune infiltration and the risk score were evaluated through the CIBERSORT algorithm and Tumor Immune Estimation Resource (TIMER) database. RESULTS: Our studies showed that individuals who had a high immune score (P=0.017) and low stromal score (P=0.041) had a favorable overall survival (OS) rate. By comparing high/low scores cohort, 220 differentially expressed genes (DEGs) were determined. Then an immune-related four-mRNA biosignature, including PDIA2, NAFTC1, VEGFC, and CD1B was identified. Kaplan-Meier, calibration, and receiver operating characteristic (ROC) curves verified the model's performance. By using univariate and multivariate Cox analyses, we found each biosignature was an independent risk factor for assessing a CC patient's survival. Three external GEO cohorts validated its good efficiency in estimating OS among individuals with CC. Moreover, the signature was also related to infiltration of several cells of the immune system in the tumor microenvironment. CONCLUSIONS: The resultant model in our study included 4 IRGs associated with the TME. These IRGs can be utilized as an auxiliary variable to estimate and help improve the prognosis of individuals with CC. 2021 Journal of Gastrointestinal Oncology. All rights reserved.
BACKGROUND: Gastrointestinal malignant cancers affect many sites in the intestinal tract, including the colon. In this study, we purposed to improve prognostic predictions for colon cancer (CC) patients by establishing a novel biosignature of immune-related genes (IRGs) based on the tumor microenvironment (TME). METHODS: Using the estimation of stromal and immune cells in malignant tumor tissues using expression data (ESTIMATE) algorithm, we calculated the stromal and immune scores of every CC patient extracted from The Cancer Genome Atlas (TCGA). We then identified 4 immune-related messenger RNA (mRNA) biosignatures through a Cox and least absolute shrinkage and selection operator (LASSO) univariate analysis, and a Cox multivariate analysis. Relationships between tumor immune infiltration and the risk score were evaluated through the CIBERSORT algorithm and Tumor Immune Estimation Resource (TIMER) database. RESULTS: Our studies showed that individuals who had a high immune score (P=0.017) and low stromal score (P=0.041) had a favorable overall survival (OS) rate. By comparing high/low scores cohort, 220 differentially expressed genes (DEGs) were determined. Then an immune-related four-mRNA biosignature, including PDIA2, NAFTC1, VEGFC, and CD1B was identified. Kaplan-Meier, calibration, and receiver operating characteristic (ROC) curves verified the model's performance. By using univariate and multivariate Cox analyses, we found each biosignature was an independent risk factor for assessing a CC patient's survival. Three external GEO cohorts validated its good efficiency in estimating OS among individuals with CC. Moreover, the signature was also related to infiltration of several cells of the immune system in the tumor microenvironment. CONCLUSIONS: The resultant model in our study included 4 IRGs associated with the TME. These IRGs can be utilized as an auxiliary variable to estimate and help improve the prognosis of individuals with CC. 2021 Journal of Gastrointestinal Oncology. All rights reserved.
Authors: Karuna Ganesh; Zsofia K Stadler; Andrea Cercek; Robin B Mendelsohn; Jinru Shia; Neil H Segal; Luis A Diaz Journal: Nat Rev Gastroenterol Hepatol Date: 2019-06 Impact factor: 46.802
Authors: Nolan Priedigkeit; Rebecca J Watters; Peter C Lucas; Ahmed Basudan; Rohit Bhargava; William Horne; Jay K Kolls; Zhou Fang; Margaret Q Rosenzweig; Adam M Brufsky; Kurt R Weiss; Steffi Oesterreich; Adrian V Lee Journal: JCI Insight Date: 2017-09-07
Authors: Debora Basile; Silvio Ken Garattini; Marta Bonotto; Elena Ongaro; Mariaelena Casagrande; Monica Cattaneo; Valentina Fanotto; Elisa De Carlo; Fotios Loupakis; Federica Urbano; Francesca V Negri; Nicoletta Pella; Marco Russano; Oronzo Brunetti; Mario Scartozzi; Daniele Santini; Nicola Silvestris; Andrea Casadei Gardini; Marco Puzzoni; Lorenzo Calvetti; Nadia Cardarelli; Giuseppe Aprile Journal: Expert Opin Biol Ther Date: 2017-04-13 Impact factor: 4.388
Authors: Manish K Tripathi; Natasha G Deane; Jing Zhu; Hanbing An; Shinji Mima; Xiaojing Wang; Sekhar Padmanabhan; Zhiao Shi; Naresh Prodduturi; Kristen K Ciombor; Xi Chen; M Kay Washington; Bing Zhang; R Daniel Beauchamp Journal: Cancer Res Date: 2014-10-15 Impact factor: 12.701
Authors: Neel Shah; Ping Wang; John Wongvipat; Wouter R Karthaus; Wassim Abida; Joshua Armenia; Shira Rockowitz; Yotam Drier; Bradley E Bernstein; Henry W Long; Matthew L Freedman; Vivek K Arora; Deyou Zheng; Charles L Sawyers Journal: Elife Date: 2017-09-11 Impact factor: 8.140
Authors: Cheng-Hsueh Lee; Lih-Chyang Chen; Chia-Cheng Yu; Wen-Hsin Lin; Victor C Lin; Chao-Yuan Huang; Te-Ling Lu; Shu-Pin Huang; Bo-Ying Bao Journal: Int J Environ Res Public Health Date: 2019-11-27 Impact factor: 3.390